Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;94:1032-1040
Published online before print March 11, 2004, doi: 10.1161/01.RES.0000125625.18597.AD
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
94/8/1032    most recent
01.RES.0000125625.18597.ADv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Versteeg, H. H.
Right arrow Articles by Peppelenbosch, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Versteeg, H. H.
Right arrow Articles by Peppelenbosch, M. P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Dietary Proteins
Related Collections
Right arrow Angiogenesis
Right arrow Apoptosis
Right arrow Coagulation
Right arrow Thrombin
Right arrow Signal transduction
(Circulation Research. 2004;94:1032.)
© 2004 American Heart Association, Inc.


Molecular Medicine

FVIIa:TF Induces Cell Survival via G12/G13-Dependent Jak/STAT Activation and BclXL Production

Henri H. Versteeg, C. Arnold Spek, Sjoukje H. Slofstra, Sander H. Diks, Dick J. Richel, Maikel P. Peppelenbosch

From the Laboratory of Experimental Internal Medicine (H.H.V., C.A.S., S.H.S., S.H.D., M.P.P.) and Department of Medical Oncology (H.H.V., D.J.R.), Academic Medical Center, Amsterdam, The Netherlands.

Correspondence to Henri H. Versteeg, Laboratory of Experimental Internal Medicine, G2-131, Academic Medical Center, Meibergdreef 9, 1105AZ Amsterdam, The Netherlands. E-mail h.h.versteeg{at}amc.uva.nl

Tissue factor (TF), apart from activating the extrinsic pathway of the blood coagulation, is a principal regulator of embryonic and oncogenic angiogenesis, inflammation, leukocyte reverse transmigration, and tumor progression. It has become clear that these events are mediated by intracellular signal transduction elicited by TF/factor VIIa (FVIIa) interaction, but the details of this signaling remain largely obscure. In this study, we show that FVIIa/TF-interaction produces STAT5 phosphorylation, STAT5 nuclear translocation and transactivation of a STAT5 reporter construct. FVIIa-dependent STAT5 activation was dependent on FVIIa proteolytic activity but not on generation of the downstream coagulation factors Xa and thrombin, nor on the TF cytoplasmic domain. FVIIa-induced STAT5 phosphorylation was dependent on functional G12/G13 class G proteins and Jak2 activity, but not Jak1 or Tyk2. Finally, we show that FVIIa leads to cell survival through a Jak2/STAT5-dependent production of the antiapoptotic STAT5 target BclXL as well as Jak2-dependent activation of the antiapoptotic protein PKB. In conclusion, our results show that FVIIa induces cell survival through STAT5-dependent BclXL production and Jak2-dependent activation of PKB. Finally, we demonstrated for the first time that TF/FVIIa-signal transduction is dependent on G12/G13 class G proteins.


Key Words: inflammation • survival • coagulation • signal transduction




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. Apostolopoulos, M. J. Hickey, L. Sharma, P. Davenport, L. Moussa, W. G. James, J. L. Gregory, A. R. Kitching, M. Li, and P. G. Tipping
The cytoplasmic domain of tissue factor in macrophages augments cutaneous delayed-type hypersensitivity
J. Leukoc. Biol., April 1, 2008; 83(4): 902 - 911.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Redecha, R. Tilley, M. Tencati, J. E. Salmon, D. Kirchhofer, N. Mackman, and G. Girardi
Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury
Blood, October 1, 2007; 110(7): 2423 - 2431.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. L. Bos, S. H. Diks, J. C.H. Hardwick, K. V. Walburg, M. P. Peppelenbosch, and D. J. Richel
Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/{beta}-catenin pathway activity
Carcinogenesis, December 1, 2006; 27(12): 2371 - 2382.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Cao, N. Dronadula, F. Rizvi, Q. Li, K. Srivastava, W. T. Gerthoffer, and G. N. Rao
Novel Role for STAT-5B in the Regulation of Hsp27-FGF-2 Axis Facilitating Thrombin-Induced Vascular Smooth Muscle Cell Growth and Motility
Circ. Res., April 14, 2006; 98(7): 913 - 922.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. V. M. Rao and U. R. Pendurthi
Tissue Factor-Factor VIIa Signaling
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 47 - 56.
[Abstract] [Full Text] [PDF]